Transactions of the Twenty-Fifth Annual Meeting of the Society for Maternal-Fetal Medicine
Fetal immune response to oral pathogens and risk of preterm birth

https://doi.org/10.1016/j.ajog.2005.05.050Get rights and content

Objective

The purpose of this study was to determine the relationship between fetal inflammatory and immune responses to oral pathogens and risk for preterm birth.

Study design

Six hundred and forty umbilical cord blood specimens were prospectively collected. Cord serum levels of C-reactive protein, interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, Prostaglandin E2, and 8-isoprostane were determined by enzyme-linked immunosorbent assay and categorized as > median (high) versus ≤ median (low). Presence of fetal immunoglobulin M (IgM) antibody against oral pathogens was determined by checkerboard immunoblot assay; detection of ≥1 oral pathogen specific antibody was categorized as positive. Preterm birth was defined as spontaneous delivery at <35 weeks. Chi-square analysis was used to determine association between cord serum mediator or IgM category and preterm birth. Odds ratios (OR) for preterm birth were calculated, stratified by mediator and IgM category.

Results

Of 640 births, 48 (7.5%) delivered preterm. Preterm birth rates were higher if categorized as high versus low 8-isoprostane or TNF-α (23 vs 5%, P < .001 and 10 vs 4%, P < .01, respectively). Preterm birth rates were also higher if categorized as IgM positive versus negative (10.6 vs 5.8%, P = .04). The joint effects of fetal IgM seropositivity, detectable C-reactive protein, or high 8-isoprostane, PGE2, or TNF-α resulted in significantly increased risk for preterm birth (adjusted OR [95% CI]: 6.0 [2.2-16.5], 4.3 [1.6-11.5], 4.1 [1.5-11.6], and 7.6 [2.3-20.8], respectively).

Conclusion

Fetal exposure to oral pathogens evidenced by an IgM response is associated with preterm birth, and the risk for preterm birth is greatest among fetuses that also demonstrate an inflammatory response.

Section snippets

Materials and methods

The Oral Conditions and Pregnancy study was a prospective, observational study designed to study maternal oral health in pregnancy and association with adverse pregnancy outcomes. Detailed methodology has been published elsewhere.1 Briefly, 1115 women were enrolled at <26 weeks' gestation. A systematic dental examination, maternal oral, vaginal, and blood specimens were collected and demographic and medical data recorded. At delivery, 10 to 20 mL of mixed arterial and venous umbilical cord was

Results

Of 1115 women enrolled in the Oral Conditions and Pregnancy study, 640 (57.4%) had umbilical cord blood collected and complete information available. Of these 640, 48 (7.5%) delivered preterm (<35 weeks). The mean, median, and range of serum inflammatory markers for the study cohort, and stratified by delivery <35 or ≥35 weeks' are shown in Table I. Increasing levels of umbilical cord serum C-reactive protein and TNF-α were associated with delivery <35 weeks' gestation (OR, 95% CI 1.8, 1.3-2.5

Comment

Our study demonstrates that fetal exposure to oral pathogens evidenced by an IgM response is associated with preterm birth at <35 weeks. Fetuses with high TNF-α or 8-isoprostane levels also demonstrate an increased risk for preterm birth, independent of fetal IgM response. Previous studies have demonstrated that a fetal inflammatory response, evidenced by umbilical cord levels of TNF-α, IL-6, or C-reactive protein, is associated with preterm birth.10, 11, 12 Our study is the first to

References (18)

There are more references available in the full text version of this article.

Cited by (76)

  • Association between maternal periapical lesions and brain inflammation in rat pups

    2013, Archives of Oral Biology
    Citation Excerpt :

    Tumour necrosis factor (TNF)-α, interleukin (IL)-1, and IL-6 are commonly associated with oral infections involving both periodontal1–9 and periapical10,11 tissues.

View all citing articles on Scopus

Supported by K08 HD043284 (K. A. B.), R01 DE12453 (S. O.), and the University of North Carolina General Clinical Research Center grant RR00046.

Presented at the Twenty-Fifth Annual Meeting of the Society for Maternal Fetal Medicine, February 7-12, 2005, Reno, Nev.

View full text